Improve Outcomes for Older Allogeneic Transplant Recipients (NCT05612789)
Intervening on Frailty to Improve Outcomes for Older Allogeneic Transplant Recipients
🩺 Plain-English Summary (8th-Grade Level)
This is an interventional pilot study to determine whether implementation of a supervised exercise program can improve outcomes in subjects undergoing allogeneic HCT. The primary objective is to determine feasibility. Up to 60-72 evaluable subjects will be enrolled. Evaluable subjects are defined as those participating in the exercise intervention.
Who can join: Review the eligibility criteria below.
Location: Penn Medicine — Philadelphia, Pennsylvania
Age range: 60 Years
🧪 Interventions in This Study
- Exercise Program (Cohort A Prehab) (BEHAVIORAL)
- Exercise Program (Cohort B Rehab) (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Penn Medicine — Philadelphia, Pennsylvania
📞 Contact the Study Coordinator
Phone: (215) 220-9675
Email: Jacqui.Rick@pennmedicine.upenn.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Allogeneic Transplantation
Explore by condition: All Allogeneic Transplantation clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.